slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 38,491-38,520
Pages 10,126
Rows per page 30
Component
38,491-38,520 of 303,780
01
Signature Bank | Results Presentation Deck | 3 slidesSignature Bank | Results Presentation Deck | 3 slides · Signature Bank
Conference presentation Investor relations Beat · Attention2 hits
02
Skillsoft | Results Presentation Deck | 14 slidesSkillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations 2 hits
01
Exhibit 99.2 identifier present.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem2 hits
07
The slide uses a comparative structure to frame gavo-cel as a superior therapeutic option compared to historical anti-mesothelin CAR-T approaches.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · AgitateLoop · Cost Of Inaction2 hits
10
Includes longitudinal CT scan imagery and a line chart tracking tumor diameter and volume reduction.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
12
The slide uses a central human anatomy diagram to map specific cancer types to their respective mesothelin expression rates.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
15
The slide uses a process diagram to illustrate the dose escalation cohorts leading to the Recommended Phase 2 Dose (RP2D).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
18
Waterfall plot is a standard clinical trial visualization for tumor response.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
22
Includes longitudinal CT scan imagery and a line chart tracking tumor diameter and volume reduction over time.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 2 hits
24
Data shows patient-specific longitudinal tracking of transgene copies/µg gDNA.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 2 hits
26
TCR2 Therapeutics | Results Presentation Deck | 34 slidesTCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 2 hits
32
Uses multiparameter immunofluorescence to visualize tumor markers (PanCK), T cells (CD3), TAMs (CD68), and inhibitory ligands (CD155, PD-L1).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 2 hits
05
The slide uses a central hub-and-spoke diagram to show the mast cell as the central point of failure/intervention.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction2 hits
06
The data highlights the mechanism of action of KIT inhibition (inactivation and depletion) supported by Phase 1b interim results.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction2 hits
08
The slide uses a staircase diagram to represent dose escalation and a crossover diagram for the food effect study.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · SolutionLoop · Cost Of Inaction2 hits
12
The slide includes a disclaimer that cross-study comparisons are unreliable due to differences in study design.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Loop · Cost Of Inaction2 hits
18
The slide uses a timeline diagram to show clinical phases and key events (trial initiation, regulatory submission, data readout) from 2H'22 to 2H'24.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Loop · Cost Of Inaction2 hits
20
Includes a patient quote and clinical imagery to emphasize the severity of the condition.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction2 hits
21
Includes medical imagery of lungs and mast cells.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction2 hits
04
The slide combines team bios with a mission statement.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · Team2 hits
05
TurnOnGreen | Investor Presentation Deck | 23 slidesTurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations 2 hits
06
The slide highlights 50+ years of expertise and lists a diverse range of clients across defense, aerospace, and commercial sectors.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations 2 hits
08
The chart uses a combination of bar (quarterly) and line (cumulative) data to demonstrate market acceleration.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · ProblemLoop · Why Now2 hits
10
The slide uses a grid layout to map product categories against specific offerings.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
11
Uses asterisks to denote current vs future goals.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
12
TurnOnGreen | Investor Presentation Deck | 23 slidesTurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
13
Shows hardware (EVP Series, EV700-EV1100, FSP/FST Fast Series) connected to a management dashboard.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
15
The slide uses a 3x3 grid to list product features.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
16
The slide uses a 3x3 grid layout to present product features.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits
17
The slide uses a 3x3 grid to list product features.TurnOnGreen | Investor Presentation Deck | 23 slides · TurnOnGreen
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet2 hits